The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10133853" target="_blank" >RIV/00179906:_____/13:10133853 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11150/13:10133853
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.019" target="_blank" >http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.019</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.atherosclerosissup.2012.10.019" target="_blank" >10.1016/j.atherosclerosissup.2012.10.019</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination
Popis výsledku v původním jazyce
Objective: Mean platelet volume is arousing increasing interest as a new independent cardiovascular risk factor. Large platelets are likely to be more reactive. If mean platelet volume would drop after LDL-lowering therapy, decreased MPV could be one ofthe markers of successful therapy. Therefore, we investigated mean platelet volume after extracorporeal LDL-cholesterol elimination. Methods: Mean platelet volume was investigated in patients with severe familial hypercholesterolemia long-term treated (3-12 years) by LDL-apheresis (immunoapheresis) or cascade filtration. Plasma was obtained by centrifugation. Adsorbers Lipopak 400 were used for immunoapheresis and filters Evaflux 4A were used for cascade filtration. 95 pair samples were measured (beforeand after the procedures) in a group of 12 patients - each patient 8 times in 4 years. Results: Mean platelet volume before the procedures was 10.891 fl, CI 10.25-11.53. Mean platelet volume after the procedures decreased - 10.478 fl, CI
Název v anglickém jazyce
The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination
Popis výsledku anglicky
Objective: Mean platelet volume is arousing increasing interest as a new independent cardiovascular risk factor. Large platelets are likely to be more reactive. If mean platelet volume would drop after LDL-lowering therapy, decreased MPV could be one ofthe markers of successful therapy. Therefore, we investigated mean platelet volume after extracorporeal LDL-cholesterol elimination. Methods: Mean platelet volume was investigated in patients with severe familial hypercholesterolemia long-term treated (3-12 years) by LDL-apheresis (immunoapheresis) or cascade filtration. Plasma was obtained by centrifugation. Adsorbers Lipopak 400 were used for immunoapheresis and filters Evaflux 4A were used for cascade filtration. 95 pair samples were measured (beforeand after the procedures) in a group of 12 patients - each patient 8 times in 4 years. Results: Mean platelet volume before the procedures was 10.891 fl, CI 10.25-11.53. Mean platelet volume after the procedures decreased - 10.478 fl, CI
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT12287" target="_blank" >NT12287: Význam insulinové resistence v patogenezi kardiometabolického rizika u diabetes mellitus</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Atherosclerosis Supplements
ISSN
1567-5688
e-ISSN
—
Svazek periodika
14
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
IE - Irsko
Počet stran výsledku
5
Strana od-do
77-81
Kód UT WoS článku
000314885000014
EID výsledku v databázi Scopus
—